Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine.
Replication of retroviral and host genomes requires ribonucleotide reductase to convert rNTPs to dNTPs, which are then used as substrates for DNA synthesis. Inhibition of ribonucleotide reductase by hydroxyurea (HU) has been previously used to treat cancers as well as HIV. However, the use of HU as...
Main Authors: | Christine L Clouser, Colleen M Holtz, Mary Mullett, Duane L Crankshaw, Jacquie E Briggs, Jay Chauhan, Ilze Matise VanHoutan, Steven E Patterson, Louis M Mansky |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3021508?pdf=render |
Similar Items
-
Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation
by: Karavana SY, et al.
Published: (2018-07-01) -
Predictive modeling of in vivo response to gemcitabine in pancreatic cancer.
by: James J Lee, et al.
Published: (2013-01-01) -
An Orally Bioavailable (Mice) Prodrug of Glutathione
by: Daune L. Crankshaw, et al.
Published: (2021-06-01) -
In vivo evaluation of the anticancer activity of the gemcitabine and doxorubicin combined in a nanoemulsion
by: Mayson H Alkhatib, et al.
Published: (2018-01-01) -
Ex Vivo and In Vivo Imaging Study of Ultrasound Capsule Endoscopy
by: Lee, John Haeseon, et al.
Published: (2021)